BenzingaSeptember 1, 2026 at 4:26 AM NY3 days ago
Wedbush Maintains Outperform on VeriSign, Raises Price Target to $341
Wedbush analyst Ygal Arounian maintains VeriSign (NASDAQ:VRSN) with a Outperform and raises the price target from $324 to $341.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga
Companies in This Story
Related Stories
Which dow jones stocks are moving on Friday?
ChartMill3 hours ago
Exploring the top movers within the S&P500 index during today's session.
ChartMill3 hours ago
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo3 hours ago
Sector Update: Financial
Yahoo4 hours ago
Should You Buy, Sell or Hold PVH Stock Post Q2 Earnings?
Yahoo5 hours ago